These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10768157)

  • 61. [Efficacy and tolerability of vigabatrin in West syndrome].
    Moraes MH; Montenegro MA; Franzon RC; Avila JO; Guerreiro MM
    Arq Neuropsiquiatr; 2005 Jun; 63(2B):469-73. PubMed ID: 16059600
    [TBL] [Abstract][Full Text] [Related]  

  • 62. No effect of long-term vigabatrin treatment on central nervous system conduction in patients with refractory epilepsy: results of a multicenter study of somatosensory and visual evoked potentials. PMS Study Multicenter Group.
    Mauguière F; Chauvel P; Dewailly J; Dousse N
    Epilepsia; 1997 Mar; 38(3):301-8. PubMed ID: 9070592
    [TBL] [Abstract][Full Text] [Related]  

  • 63. LIS1-associated classic lissencephaly: A retrospective, multicenter survey of the epileptogenic phenotype and response to antiepileptic drugs.
    Herbst SM; Proepper CR; Geis T; Borggraefe I; Hahn A; Debus O; Haeussler M; von Gersdorff G; Kurlemann G; Ensslen M; Beaud N; Budde J; Gilbert M; Heiming R; Morgner R; Philippi H; Ross S; Strobl-Wildemann G; Muelleder K; Vosschulte P; Morris-Rosendahl DJ; Schuierer G; Hehr U
    Brain Dev; 2016 Apr; 38(4):399-406. PubMed ID: 26494205
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sabril® registry 5-year results: Characteristics of adult patients treated with vigabatrin.
    Krauss G; Faught E; Foroozan R; Pellock JM; Sergott RC; Shields WD; Ziemann A; Dribinsky Y; Lee D; Torri S; Othman F; Isojarvi J
    Epilepsy Behav; 2016 Mar; 56():15-9. PubMed ID: 26807550
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vigabatrin in drug-resistant partial epilepsy: a 5-year follow-up study.
    Sivenius J; Ylinen A; Murros K; Mumford JP; Riekkinen PJ
    Neurology; 1991 Apr; 41(4):562-5. PubMed ID: 1901397
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effect of vigabatrin (gamma-vinyl GABA) on cerebral blood flow and metabolism.
    Spanaki MV; Siegel H; Kopylev L; Fazilat S; Dean A; Liow K; Ben-Menachem E; Gaillard WD; Theodore WH
    Neurology; 1999 Oct; 53(7):1518-22. PubMed ID: 10534261
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vigabatrin in childhood epilepsy: comparable efficacy for generalized and partial seizures.
    Sheth RD; Buckley D; Penney S; Hobbs GR
    Clin Neuropharmacol; 1996 Aug; 19(4):297-304. PubMed ID: 8828992
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vigabatrin in uncontrolled seizures: Belgian clinical experience. The Belgian Vigabatrin Evaluation Group.
    Lhoir A
    Clin Neurol Neurosurg; 1994 Feb; 96(1):42-6. PubMed ID: 8187381
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vigabatrin: a novel therapy for seizure disorders.
    Gidal BE; Privitera MD; Sheth RD; Gilman JT
    Ann Pharmacother; 1999 Dec; 33(12):1277-86. PubMed ID: 10630829
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of vigabatrin addition on carbamazepine blood serum levels in patients with epilepsy.
    Jedrzejczak J; Dławichowska E; Owczarek K; Majkowski J
    Epilepsy Res; 2000 Apr; 39(2):115-20. PubMed ID: 10759299
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Vigabatrin therapy for refractory complex partial seizures: review of major European trials.
    Ben-Menachem E; Sander JW
    Acta Neurol Scand Suppl; 2011; (192):16-28. PubMed ID: 22061177
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy, safety, and tolerability of imepitoin in dogs with newly diagnosed epilepsy in a randomized controlled clinical study with long-term follow up.
    Rundfeldt C; Tipold A; Löscher W
    BMC Vet Res; 2015 Sep; 11():228. PubMed ID: 26330063
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study.
    Kälviäinen R; Aikiä M; Saukkonen AM; Mervaala E; Riekkinen PJ
    Arch Neurol; 1995 Oct; 52(10):989-96. PubMed ID: 7575227
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Neurofeedback therapy influence on clinical status and some EEG parameters in children with localized epilepsy].
    Kubik P; Stanios M; Iwan E; Kubik A
    Przegl Lek; 2016; 73(3):157-60. PubMed ID: 27349045
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vigabatrin in adults with poorly-controlled epilepsy and learning disabilities.
    Armour DJ; Fidler C; Wright EC; Balarajan S
    Seizure; 1992 Sep; 1(3):157-62. PubMed ID: 1344760
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Vigabatrin.
    Guberman A
    Can J Neurol Sci; 1996 Nov; 23(4 Suppl 2):S13-7. PubMed ID: 8951215
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy of Topiramate as an add-on drug in seizures in Indian children--an observational study.
    Sreenivasan P; Kunju PA
    Indian J Pediatr; 2011 Oct; 78(10):1221-4. PubMed ID: 21373827
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long-term antiepileptic efficacy of vigabatrin in drug-refractory epilepsy in mentally retarded patients. A 5-year follow-up study.
    Pitkänen A; Ylinen A; Matilainen R; Luukkainen R; Mervaala E; Seppänen R; Ruutiainen T; Riekkinen PJ
    Arch Neurol; 1993 Jan; 50(1):24-9. PubMed ID: 8418797
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy.
    Dodrill CB; Arnett JL; Sommerville KW; Sussman NM
    Epilepsia; 1995 Feb; 36(2):164-73. PubMed ID: 7821274
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Single-blind, placebo-controlled multicenter trial of vigabatrin in the treatment of epilepsy. The Italian Study Group on Vigabatrin.
    Ital J Neurol Sci; 1992 Dec; 13(9):741-7. PubMed ID: 1483856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.